Overview of Dr. Chakraborty
Dr. Rajshekhar Chakraborty is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from University of Arkansas for Medical Sciences (UAMS) College of Medicine and has been in practice 9 years. He is one of 121 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center and one of 370 doctors at New York-Presbyterian Hospital who specialize in Oncology. He has more than 100 publications and over 500 citings.
Office
161 Fort Washington Ave
New York, NY 10032Fax+1 212-305-6891
Education & Training
Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2017 - 2020
University of Arkansas For Medical Sciences College of MedicineClass of 2010- Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology
Certifications & Licensure
NY State Medical License 2020 - 2025
OH State Medical License 2017 - 2021
MN State Medical License 2014 - 2017
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Treatment of Refractory Monoclonal Immunoglobulin Deposition Disease With BCMA Bispecific Antibody.Divaya Bhutani, Rajshekhar Chakraborty, Karan Wats, Michael Sang Hughes, Lotan Dor
European Journal of Haematology. 2025-04-01 - A model for predicting day-100 stem cell transplant-related mortality in AL amyloidosis.Eli Muchtar, Angela Dispenzieri, Vaishali Sanchorawala, Hamza Hassan, Raphael Mwangi
Bone Marrow Transplantation. 2025-02-24 - Improved Outcomes of Myeloma Cast Nephropathy in Newly Diagnosed Multiple Myeloma With Modern Anti-Myeloma Therapies.Michael Sang Hughes, Metodi Balev, Jai Radhakrishnan, Divaya Bhutani, Markus Mapara
European Journal of Haematology. 2025-02-24
Abstracts/Posters
- Risk of Serious Infections with Carfilzomib in Patients with Multiple Myeloma: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsRajshekhar Chakraborty, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Venous thromboembolism risk with contemporary lenalidomide-based regimes for multiple myeloma: A systematic review and meta-analysis.ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
- Depth of Pre-Treatment Immunoparesis Is an Important Prognostic Factor for Survival in Relapsed Multiple Myeloma61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
